ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL (Pinksheets: BIOQ):
|
2012 |
2011 |
|||||
| Revenue | $ | 22,667,149 | $ | 23,298,689 | ||
| Income Before Income Tax | $ | 362,199 | $ | 682,304 | ||
| Net Income | $ | 213,971 | $ | 401,662 | ||
| Basic Earnings per Share | ||||||
| of Common Stock | $ | .24 | $ | .45 | ||
| Diluted Earnings per Share | ||||||
| of Common Stock | $ | .24 | $ | .45 | ||
| Weighted Average | ||||||
| Number of Shares Outstanding | ||||||
| For Basic Earnings | 895,994 | 900,017 | ||||
| Weighted Average | ||||||
| Number of Shares Outstanding | ||||||
| For Diluted Earnings | 895,994 | 900,017 | ||||
BIOQUAL’s Board of Directors has declared a dividend of $0.16 per share for shareholders of record on November 28, 2012, payable on December 18, 2012. This is the twelfth dividend declared by BIOQUAL.
Statements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the actual cost incurred in performing its contracts; uncertainties relating to clinical trials; dependence on third parties; and future capital needs.